Save Article The Canadian cannabis stocks on our list are notable exclusions from the HMMJ Index but offer upside with their inclusion in the Horizons Emerging Growers (HMJR) Index
SmallCapPower | October 25, 2018: Horizons offers different Exchange Traded Funds (ETFs) to consumers sourced from a variety of industries. Over the past year Horizon’s notable ETFs have been sourced from the cannabis industry with the Horizons Marijuana Life Sciences Index (TSX:HMMJ) and the lesser known Horizons Emerging Growers Index (TSX:HMJR). While both ETFs offer exposure to North American cannabis companies, HMJR focuses on small-cap companies and omit major players such as Canopy Growth Corp (TSX:WEED). Today, we have identified four key Canadian cannabis stocks included in HMJR but are excluded from HMMJ. These companies should benefit from the inclusion in HMJR and can offer high returns for investors with some tolerance for greater risk.
Sproutly Canada Inc. (CSE:SPR) – $0.70Cannabis
Sproutly Canada is focused on becoming the leading supplier of cannabis beverages and edibles to the international recreational market. The Company has a Toronto based, 16,600 sq. ft. indoor production facility capable of producing 1,400 kg of cannabis per year. Sproutly has a partnership with Infusion Biosciences for exclusive rights to Infusion’s APP Technology, which can produce water-soluble cannabis beverages. The Company’s process is currently patent pending, with Sproutly having exclusive rights for the technology in Canada, U.K., EU, Israel, Australia and Jamaica.
Valens Groworks Corp. (CSE:VGW) – $1.85Cannabis
Valens Groworks is a Vancouver-based cannabis oil producer with three subsidiaries in the Okanagan Valley region: Valens Agritech Ltd, Valens Farm and Supra THC Services Inc. Valens Agritech operates a 25,000 sq. ft. cannabis extraction and cultivation facility and holds an EU GMP certification for global exporting. Valens Farms, which is currently under construction, will operate a 400,000 sq. ft. cannabis cultivation facility that grows cannabis through monocropping methodology to increase annual crop turnover. Supra THC Services operates a cannabis research laboratory that will be responsible for testing and analyzing the quality of Valens’ cannabis products. Supra THC is the first cannabis laboratory in the world to receive the Thermo Fisher “Center of Excellence in Plant Based Medicines” recognition.
Ascent Industries Corp. (CSE:ASNT) – $0.56Cannabis
Ascent Industries operates cannabis production and distribution facilities in Canada, Oregon, and Nevada. The Company currently has three production facilities in British Columbia: Agrima Botanicals, Agrima Labs, and Agrima Meadows. The Company’ flagship indoor cultivation facility reached full capacity in August with average production of 1.5kg per 1000-watt light. The Company has formed distribution partnerships with Aurora Cannabis, the Ontario Cannabis Retail Corporation and the British Columbia Liquor Distribution Board; research partnerships with Simon Fraser University to identify therapeutic benefits for cannabinoids; and supply agreements with Australia’s ANTG for up to 10,000 kg of medicinal cannabis per year.
Planet 13 Holdings Inc. (CSE:PLTH) – $2.38Cannabis
Planet 13 Holdings operates cannabis cultivation facilities and dispensaries across Nevada. The Company has a total cultivation capacity of 2,100 lbs/year from its two cultivation facilities in Las Vegas and Beatty, Nevada. Planet 13 is set to launch its largest dispensary, the Planet 13 Superstore, in November located adjacent to the Las Vegas strip. The dispensary is projected to serve over 2,000 customers daily and is expected to cover more than 40,000 square feet.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.